We used Taqman qPCR to investigate the correlation between the differential methylation of IRF6, SLFN12, and RNF39 with their gene expression at baseline and after the first cycle of DOX chemotherapy in PBMCs of breast cancer patients (Supplementary Tables S6–S8). This evidence concerns the gene IRF6 and breast carcinoma.